Report Home For many years, generic drugs have been a key tool for helping consumers, health insurers, and public payers to reduce their prescription drug costs. Their availability is particularly important in view of renewed rapid health care cost increases, a substantial share of which is attributed to prescription drugs. At the same time, the cost savings should not be considered separately from quality of care issues. In this AARP Public Policy Institute Issue Brief, David Gross provides basic information about generic drugs, focusing on their contribution to reducing prescription drug costs; the generic drug approval process; evidence on generic drug safety and effectiveness; state laws regarding generic substitution; and provider and consumer attitudes toward generic drugs. (18 pages) Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Close In the next 24 hours, you will receive an email to confirm your subscription to receive emails related to AARP volunteering. Once you confirm that subscription, you will regularly receive communications related to AARP volunteering. In the meantime, please feel free to search for ways to make a difference in your community at Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.